ecancermedicalscience

Conference Report

Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

9 Nov 2016
Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada

This report covers the Immunotherapy sessions of the 2016 Organisation of European Cancer Institutes (OECI) Oncology Days meeting, which was held on 15th–17th June 2016 in Brussels, Belgium. Immunotherapy is a potential cancer treatment that uses an individual’s immune system to fight the tumour. In recent years significant advances have been made in this field in the treatment of several advanced cancers. Cancer immunotherapies include monoclonal antibodies that are designed to attack a very specific part of the cancer cell and immune checkpoint inhibitors which are molecules that stimulate or block the inhibition of the immune system. Other cancer immunotherapies include vaccines and T cell infusions. This report will summarise some of the research that is going on in this field and will give us an update on where we are at present.

Related Articles

Marcello Moro Queiroz, Zenaide Silva de Souza, Aline Bobato Lara Gongora, Felipe de Galiza Barbosa, Carlos Alberto Buchpiguel, Marilia Germanos de Castro, Mariana Petaccia de Macedo, Rafael Ferreira Coelho, Ethan Samuel Sokol, Anamaria Aranha Camargo, Diogo Assed Bastos
Don Thiwanka Wijeratne, Christopher M Booth, Sanjeewa Seneviratne, Bishal Gyawali, Matt Jalink, Malinthi Soysa, Sachith Abhayaratna, Hasitha Promod, Punika Wijesinghe, Sanjeeva Gunasekera
Prasanth S Ariyannur, Reenu Anne Joy, Veena Menon, Roopa Rachel Paulose, Keechilat Pavithran, Damodaran M Vasudevan